Journal article
Quantitative Cultures of Bronchoscopically Obtained Specimens Should Be Performed for Optimal Management of Ventilator-Associated Pneumonia
Journal of Clinical Microbiology, Vol.51(3), pp.740-744
03/01/2013
DOI: 10.1128/JCM.03383-12
PMCID: PMC3592072
PMID: 23284021
Abstract
Ventilator-associated pneumonia (VAP) is a leading cause of health care-associated infection. It has a high rate of attributed mortality, and this mortality is increased in patients who do not receive appropriate empirical antimicrobial therapy. As a result of the overuse of broad-spectrum antimicrobials such as the carbapenems, strains of Acinetobacter, Enterobacteriaceae, and Pseudomonas aeruginosa susceptible only to polymyxins and tigecycline have emerged as important causes of VAP. The need to accurately diagnose VAP so that appropriate discontinuation or de-escalation of antimicrobial therapy can be initiated to reduce this antimicrobial pressure is essential. Practice guidelines for the diagnosis of VAP advocate the use of bronchoalveolar lavage (BAL) fluid obtained either bronchoscopically or by the use of a catheter passed through the endotracheal tube. The CDC recommends that quantitative cultures be performed on these specimens, using ≥104 CFU/ml to designate a positive culture (http://www.cdc.gov/nhsn/TOC_PSCManual.html, accessed 30 October 2012). However, there is no consensus in the clinical microbiology community as to whether these specimens should be cultured quantitatively, using the aforementioned designated bacterial cell count to designate infection, or by a semiquantitative approach. We have asked Vickie Baselski, University of Tennessee Health Science Center, who was the lead author on one of the seminal papers on quantitative BAL fluid culture, to explain why she believes that quantitative BAL fluid cultures are the optimal strategy for VAP diagnosis. We have Stacey Klutts, University of Iowa, to advocate the semiquantitative approach.
Details
- Title: Subtitle
- Quantitative Cultures of Bronchoscopically Obtained Specimens Should Be Performed for Optimal Management of Ventilator-Associated Pneumonia
- Creators
- Vickie BaselskiJ. Stacey Klutts
- Resource Type
- Journal article
- Publication Details
- Journal of Clinical Microbiology, Vol.51(3), pp.740-744
- Publisher
- American Society for Microbiology
- DOI
- 10.1128/JCM.03383-12
- PMID
- 23284021
- PMCID
- PMC3592072
- ISSN
- 0095-1137
- eISSN
- 1098-660X
- Language
- English
- Date published
- 03/01/2013
- Academic Unit
- Pathology
- Record Identifier
- 9984047744802771
Metrics
13 Record Views